Health and Fitness Health and Fitness
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
Thu, September 2, 2010

Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference


//health-fitness.news-articles.net/content/2010/ .. -at-the-ubs-global-life-sciences-conference.html
Published in Health and Fitness on Tuesday, September 14th 2010 at 5:12 GMT by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Tuesday, September 21st at 4:30 p.m. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for 30 days following the conference.

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor® (doxepin), now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the companya™s web site at [ www.somaxon.com ].


Publication Contributing Sources